Dorsal subthalamotomy for Parkinson's disease

Area of Science:

• Neurosurgery
• Neurology
• Movement Disorders

Background:

• Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting motor function.
• Current treatments for PD have limitations, necessitating exploration of novel therapeutic strategies.
• Unilateral subthalamotomy is an emerging surgical intervention targeting motor symptoms.

Purpose of the Study:

• To evaluate the safety and efficacy of unilateral subthalamotomy in patients with Parkinson's disease.
• To assess the impact of subthalamic nucleus (STN) lesioning on motor function and medication requirements.
• To determine the long-term motor outcomes and potential complications of the procedure.

Main Methods:

• Pilot, open-labeled study involving eleven Parkinson's disease patients.
• Unilateral lesioning of the sensorimotor region of the subthalamic nucleus (STN).
• Follow-up assessments conducted at 1, 6, 12, and 24 months using Core Assessment Program for Intracerebral Transplantation (CAPIT) guidelines.

Main Results:

• Significant reduction in Unified Parkinson's Disease Rating Scale (UPDRS) parts II and III motor scores in the 'off' state at 1, 6, and 12 months.
• Motor benefits were sustained up to 24 months in four patients.
• No significant change in postoperative dyskinesia scores; hemiballismus was not a common complication.

Conclusions:

• Unilateral subthalamotomy can provide considerable motor benefit for Parkinson's disease patients.
• The procedure appears safe, with hemiballismus not being a general complication.
• Subthalamotomy presents a potential surgical option for select Parkinson's disease patients.